Clinical Trial Update: Chatbot for Depression, Anxiety, and Eating Disorders [NA]

View source ↗

Summary

A Dartmouth-Hitchcock Medical Center trial evaluating a chatbot for depression, anxiety, and eating disorders has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anxiety Disorders
• Eating Disorders
• Major Depressive Disorder

Snippet

Sponsor: Dartmouth-Hitchcock Medical Center | Conditions: Depression, Anxiety | NA | Status: COMPLETED